Kathera Bioscience
Kathera Bioscience is developing therapies to treat fungal infections that are a major cause of human disease.
Kathera Bioscience is active in the biotechnology space based in Greater New York Area, East Coast, Northeastern US, founded in 2020.
Its activity falls under biotechnology; the profile below is assembled from public directory data.
The company is recorded as being based in Greater New York Area, East Coast, Northeastern US.
Its current recorded stage is Grant.
The company reports a headcount in the c_00001_00010 range.
Total disclosed funding stands at about $15K.
| Sector | Biotechnology |
|---|---|
| Headquarters | Greater New York Area, East Coast, Northeastern US |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $150,000 |
Website: katherabio.com
Browse related
Sign in to view the contact information we hold for Kathera Bioscience.
Create a free account
Create a free account